A research group from the Jacobs School of medicine and Biomedical Sciences presented numerous abstracts and earned a scholarship award for the third year in a row at the annual American Thoracic ...
Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious underserved diseases, today announced ...